Pittsburgh Business Times- UPMC Enterprises, the medical technology investment arm of UPMC, has purchased interest in RxAnte, a company that uses analytics to predict how patients will adhere to the medications they’re prescribed.
RxAnte will continue to operate as an independent company, and the investment from UPMC Enterprises will allow it to expand its offerings for Medicare, Medicaid and commercial populations, and to extend its predictive models and workflow tools to high-cost specialty drugs.
Recent Posts
Why I Moved to Pittsburgh – Machine Learning Edition
Pittsburgh’s tech scene has grown by leaps and bounds over the past few years. As a result, more and more tech talent is moving to the ‘burgh. Meet three members of our Machine Learning team who packed up and made the permanent move to the Steel City.
Read More →
(Im)moral Immortality: Is it Right to Live Forever?
As discussions around population growth, advances in medicine, and health care spending continue to increase, …
Read More →
What does it take to create successful patient engagement?
Patient engagement is a cornerstone to successful care delivery in today’s competitive, consumer-driven healthcare ecosystem and creating consistently positive patient experiences requires consistent processes.
Read More →